Tenders/Development and development of an innovative solution – a complex, two-component medicinal product, aimed at treating arterial hypertension” under the European Funds for Modern Economy 2021-2027 program, action “SMART Path”, within Priority 1 “Support for entrepreneurs”. Development and development of an innovative solution – a complex, two-component medicinal
Open🇵🇱PolandServices

Development and development of an innovative solution – a complex, two-component medicinal product, aimed at treating arterial hypertension” under the European Funds for Modern Economy 2021-2027 program, action “SMART Path”, within Priority 1 “Support for entrepreneurs”. Development and development of an innovative solution – a complex, two-component medicinal

Auto-translated from Polish
Original title: Opracowanie i rozwój innowacyjnego rozwiązania – złożonego, dwuskładnikowego produktu leczniczego, ukierunkowanego na terapię nadciśnienia tętniczego” w ramach programu Fundusze Europejskie dla Nowoczesnej Gospodarki 2021-2027, działanie „Ścieżka SMART”, w ramach 1 Priorytetu „Wsparcie dla przedsiębiorców”. Development and development of an innovative solution – a complex, two-component medicinal product aimed at the therapy of hypertension" under the European Funds for Modern Economy 2021-2027
Zakłady Farmaceutyczne Polpharma S.A.
Published: Oct 11, 2026
Updated: Oct 16, 2026
Source: Baza Konkurencyjności

About This Opportunity

This is a services contract in the health and medical services, Research and media and communication sectors, with a focus on Public Relations. Located in Poland, Europe, this opportunity is open to firms and consortiums.

Published through Baza Konkurencyjności, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for services in the health and medical services sector. Service contracts are typically evaluated on both technical quality and price, and may require bidders to demonstrate relevant experience and qualified personnel. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Auto-translated from Polish
LERCAN/7/PR 177991/ 2026-130337-293977 Implementation of research services involving a comprehensive retrospective Real-World Evidence (RWE) study in the field of arterial hypertension, carried out on

Data provenance

This notice is sourced from Baza Konkurencyjności and was originally published on October 11, 2026. Last refreshed 22 days ago. Original language: Polish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

Frequently asked questions about this tender

Who is the contracting authority?

This notice was issued by Zakłady Farmaceutyczne Polpharma S.A. in Poland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Services contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Poland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit Baza Konkurencyjności to access the full notice, required documents, and submission instructions provided by the contracting authority.

Find tenders like this automatically

Premium shows the full details of every tender like this one and alerts you instantly when a new one is published.

See plans